- Products
- Instruments & Software
- Consumables (Reagents & kits)
- Services
- Sequencing Services
- Data Analysis Services
Asia Pacific Next Generation Sequencing Market size was valued at USD 570 million in 2022 and is poised to grow at a CAGR of 24.0% from 2024-2030. Massively parallel sequencing (MPS) is another name for next-generation sequencing (NGS) . This word refers to a DNA sequencing method that has benefited biotech, forensic biology, medical diagnosis, biological systematics, and virology. NGS has evolved as a method for completing clinical research, basic science, and applied science. In comparison to the earlier Sanger sequencing method, next-generation sequencing allows a full human genome to be sequenced in a fraction of the time. With the help of next-generation sequencing (NGS), personalized oncology care has advanced significantly. The sequencing of malignant DNA is now possible quickly and affordably, revolutionizing the study of cancer treatments. The industry is anticipated to be significantly impacted by advancements in oncology and personalized medicine. Using NGS in a clinical environment opens up a number of exciting possibilities. As a result, each of these has an important influence on market expansion.
Asia Pacific Next Generation Sequencing Market Dynamics
Divers: Platforms for next-generation sequencing (NGS) have progressed, The cost of genomic sequencing is decreasing, Regulatory and reimbursement scenarios for NGS-based diagnostic assays are improving. Restraints: Budget limits for end users in developing countries.
Country Analysis
Asia Pacific Next Generation Sequencing Market
Based on by type, the product & service segments are expected to reach high growth in China during the forecast period. The increasing in the usage of Next Generation Sequencing is high in the apac region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Asia Pacific Next Generation Sequencing Market Segmentation
By Type
By Technology
- Whole Targeted Re-sequencing
- Whole Genome Sequencing
- Transcriptome (RNA-Seq)
- Whole Exome Sequencing
- De Novo Sequencing
- ChiP Sequencing
- Methylation Sequencing
- Others
By Application
- Diagnostics
- Drug Discovery & Development
- Biomarker Discovery
- Agriculture & Animal Health Research
- Personalised Medicine
By End User
- Academic Institutes & Research Centers
- Hospital/Clinical Laboratories
- Biotech/Pharmaceuticals Companies
- Others
Frequently Asked Questions
The asia pacific next generation sequencing market size was valued USD 570 million in 2022
The report covers the countries market data: China, India, Japan, Australia & New Zealand
Agilent Technologies Inc. BGI (Beijing Genomics Institute) Biomatters Ltd. DNASTAR Inc. GATC Biotech Ag Genomatix Software GmbH Illumina Incorporated
| 1.Executive Summary |
| 2. Asia Pacific Next Generation Sequencing (NGS) Market Introduction |
| 2.1. Asia Pacific Next Generation Sequencing (NGS) Market - Taxonomy |
| 2.2. Asia Pacific Next Generation Sequencing (NGS) Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Technology |
| 2.2.3.Application |
| 2.2.4.End User |
| 2.2.5.Country |
| 3. Asia Pacific Next Generation Sequencing (NGS) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Asia Pacific Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Asia Pacific Next Generation Sequencing (NGS) Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Product |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Service |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Asia Pacific Next Generation Sequencing (NGS) Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Whole Targeted Re-sequencing |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Whole Genome Sequencing |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Transcriptome (RNA-Seq) |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Whole Exome Sequencing |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. De Novo Sequencing |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. ChiP Sequencing |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Methylation Sequencing |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Others |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7. Asia Pacific Next Generation Sequencing (NGS) Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Diagnostics |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Drug Discovery & Development |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Biomarker Discovery |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Agriculture & Animal Health Research |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Personalised Medicine |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Asia Pacific Next Generation Sequencing (NGS) Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Academic Institutes & Research Centers |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Hospital/Clinical Laboratories |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Biotech/Pharmaceuticals Companies |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Asia Pacific Next Generation Sequencing (NGS) Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. China |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. India |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Australia and New Zealand (ANZ) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Japan |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Rest of APAC |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.China Asia Pacific Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Product |
| 10.1.2.Service |
| 10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Whole Targeted Re-sequencing |
| 10.2.2.Whole Genome Sequencing |
| 10.2.3.Transcriptome (RNA-Seq) |
| 10.2.4.Whole Exome Sequencing |
| 10.2.5.De Novo Sequencing |
| 10.2.6.ChiP Sequencing |
| 10.2.7.Methylation Sequencing |
| 10.2.8.Others |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Diagnostics |
| 10.3.2.Drug Discovery & Development |
| 10.3.3.Biomarker Discovery |
| 10.3.4.Agriculture & Animal Health Research |
| 10.3.5.Personalised Medicine |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Academic Institutes & Research Centers |
| 10.4.2.Hospital/Clinical Laboratories |
| 10.4.3.Biotech/Pharmaceuticals Companies |
| 10.4.4.Others |
| 11.India Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Product |
| 11.1.2.Service |
| 11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Whole Targeted Re-sequencing |
| 11.2.2.Whole Genome Sequencing |
| 11.2.3.Transcriptome (RNA-Seq) |
| 11.2.4.Whole Exome Sequencing |
| 11.2.5.De Novo Sequencing |
| 11.2.6.ChiP Sequencing |
| 11.2.7.Methylation Sequencing |
| 11.2.8.Others |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Diagnostics |
| 11.3.2.Drug Discovery & Development |
| 11.3.3.Biomarker Discovery |
| 11.3.4.Agriculture & Animal Health Research |
| 11.3.5.Personalised Medicine |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Academic Institutes & Research Centers |
| 11.4.2.Hospital/Clinical Laboratories |
| 11.4.3.Biotech/Pharmaceuticals Companies |
| 11.4.4.Others |
| 12.Australia and New Zealand (ANZ) Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Product |
| 12.1.2.Service |
| 12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Whole Targeted Re-sequencing |
| 12.2.2.Whole Genome Sequencing |
| 12.2.3.Transcriptome (RNA-Seq) |
| 12.2.4.Whole Exome Sequencing |
| 12.2.5.De Novo Sequencing |
| 12.2.6.ChiP Sequencing |
| 12.2.7.Methylation Sequencing |
| 12.2.8.Others |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Diagnostics |
| 12.3.2.Drug Discovery & Development |
| 12.3.3.Biomarker Discovery |
| 12.3.4.Agriculture & Animal Health Research |
| 12.3.5.Personalised Medicine |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Academic Institutes & Research Centers |
| 12.4.2.Hospital/Clinical Laboratories |
| 12.4.3.Biotech/Pharmaceuticals Companies |
| 12.4.4.Others |
| 13.Japan Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Product |
| 13.1.2.Service |
| 13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Whole Targeted Re-sequencing |
| 13.2.2.Whole Genome Sequencing |
| 13.2.3.Transcriptome (RNA-Seq) |
| 13.2.4.Whole Exome Sequencing |
| 13.2.5.De Novo Sequencing |
| 13.2.6.ChiP Sequencing |
| 13.2.7.Methylation Sequencing |
| 13.2.8.Others |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Diagnostics |
| 13.3.2.Drug Discovery & Development |
| 13.3.3.Biomarker Discovery |
| 13.3.4.Agriculture & Animal Health Research |
| 13.3.5.Personalised Medicine |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Academic Institutes & Research Centers |
| 13.4.2.Hospital/Clinical Laboratories |
| 13.4.3.Biotech/Pharmaceuticals Companies |
| 13.4.4.Others |
| 14.Rest of APAC Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Product |
| 14.1.2.Service |
| 14.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Whole Targeted Re-sequencing |
| 14.2.2.Whole Genome Sequencing |
| 14.2.3.Transcriptome (RNA-Seq) |
| 14.2.4.Whole Exome Sequencing |
| 14.2.5.De Novo Sequencing |
| 14.2.6.ChiP Sequencing |
| 14.2.7.Methylation Sequencing |
| 14.2.8.Others |
| 14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Diagnostics |
| 14.3.2.Drug Discovery & Development |
| 14.3.3.Biomarker Discovery |
| 14.3.4.Agriculture & Animal Health Research |
| 14.3.5.Personalised Medicine |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Academic Institutes & Research Centers |
| 14.4.2.Hospital/Clinical Laboratories |
| 14.4.3.Biotech/Pharmaceuticals Companies |
| 14.4.4.Others |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Agilent Technologies Inc. |
| 15.2.2.BGI (Beijing Genomics Institute) |
| 15.2.3.Biomatters Ltd. |
| 15.2.4.DNASTAR Inc. |
| 15.2.5.GATC Biotech Ag |
| 15.2.6.Genomatix Software GmbH |
| 15.2.7.Illumina Incorporated |
| 15.2.8.Knome Inc. |
| 15.2.9.Life Sciences (Roche) |
| 15.2.10.Macrogen Inc. |
| 15.2.11.Oxford Nanopore Technologies Ltd. |
| 15.2.12.Pacific Biosciences |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Agilent Technologies Inc.
- BGI (Beijing Genomics Institute)
- Biomatters Ltd.
- DNASTAR Inc.
- GATC Biotech Ag
- Genomatix Software GmbH
- Illumina Incorporated
- Knome Inc.
- Life Sciences (Roche)
- Macrogen Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences
- Partek Inc.
- Perkin Elmer Inc.
- Qiagen N.V
- Thermo Fischer Scientific